KRT19 and neoplasm: The tumor stroma seems to be a pretty important player and is often a barrier to treatment, making the Panc01 tumors physiologically relevant for preclinical testing46–48. Additionally, agreeing with our reported pathologic evaluation that there are no ductal formations and with previous studies, we did not find ductal cell maker CK19 on our Pan02 tumors49.